This study develops and validates a prognostic staging framework for Alzheimer’s disease by integrating cognitive status with blood-based biomarkers, and neuroimaging data, to improve risk stratification across the disease continuum.
- Daeun Shin
- Sungjoo Lee
- Kyunga Kim